Company: ACTG
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000934549-25-000054
Chunk: 195

Company: ACACIA RESEARCH CORP
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 2
Chunk 195
---

Our working capital related to cash flows from operating activities at September 30, 2025 decreased to $23.9 million, compared to $36.7 million at December 31, 2024, which was comprised of the changes in assets and liabilities presented above. The decrease is primarily due to the change in prepaid expenses related to the 2025 patent portfolio acquisition related to Intellectual Property Operations.

Cash Flows used in Investing Activities

Cash flows used in investing activities were comprised of the following for the periods presented:

Nine Months Ended September 30,20252024(In thousands)Acquisition, net of cash acquired and working capital adjustments (Note 3)$1,230 $— Patent acquisition— (14,000)Purchases of equity securities(17,368)(15,544)Sales of equity securities15,165 57,854 Purchases of loans receivable(3,364)— Purchases of property and equipment(1,401)(890)Net additions to oil and gas properties(8,961)(144,487)Net cash used in investing activities$(14,699)$(117,067)

Cash flows used in investing activities for the nine months ended September 30, 2025 were $14.7 million, as compared to cash outflows of $117.1 million in the prior year, primarily due to the 2024 net cash outflows related to the acquisition of  the Revolution assets offset by cash inflows from the sale of Arix shares.

Cash Flows from (used in) Financing Activities

Cash flows from (used in) financing activities included the following for the periods presented:

Nine Months Ended September 30,20252024(In thousands)Repurchase of common stock$— $(7,303)Contributions from noncontrolling interest— 15,250 Borrowings on the Benchmark revolving credit facility4,000 71,475 Paydown of Benchmark revolving credit facility(12,000)(12,000)Paydown of Deflecto facility(12,100)— Taxes paid related to net share settlement of share-based awards(670)(1,068)Proceeds from exercise of stock options30 223 Net cash (used in) provided by financing activities$(20,740)$66,577 

62

Cash flows used in financing activities for the nine months ended September 30, 2025 were $20.7 million, as compared to cash inflows of $66.6 million